CDC: Prior infection plus vaccination tied to lower COVID-19 case rates
By
Alicia Lasek
Jan 20, 2022
A new public health study suggests not only that vaccination protects against developing severe illness, but that surviving a bout with COVID-19 prevents reinfection, investigators say.
Almost half of US veterans had long COVID symptoms up to 6 months after infection, study finds
By
Kristen Fischer
Nov 21, 2023
A new study sheds light on the number of US veterans with long COVID, and details how long they experienced lingering symptoms. There’s not much data on long COVID and veterans, which is why the authors...
Docs push for new COVID-19 funding as signs point to rebound in U.S. omicron cases
By
Alicia Lasek
Mar 17, 2022
The alternative is to risk leaving patients without access to needed vaccines, treatments and testing, the American College of Physicians has told Congress.
Novavax COVID-19 shot gets green light as new variant spreads
By
Kristen Fischer
Nov 29, 2023
The World Health Organization (WHO) has given Novavax approval for its updated COVID-19 vaccine. This occurred as the prevalence of a highly mutated COVID variant has tripled in the past two weeks, according...
New COVID-19 test kits promised as LTC operators contend with shortages, slow PCR results
By
Alicia Lasek
Feb 03, 2022
Five million Celltion brand rapid tests will be shipped over a five-week period to facilities as they contend with testing supply shortages and slow lab turnaround times.
Long COVID symptoms lasted 3 years after infection for half of those infected, study finds
By
Kristen Fischer
Nov 28, 2023
If there’s one thing we know for sure about long COVID it’s that the symptoms can linger. A new study shows just how long symptoms can persist.
Symptomless COVID infections found in almost half of US adults, CDC says
By
Alicia Lasek
Dec 05, 2022
Approximately 44% of US adults were “possibly asymptomatically infected,” between August 2021 and May 2022, blood serum evidence shows.
Report: 1 in 5 will rebound after Paxlovid, but it still works
By
Kristen Fischer
Nov 14, 2023
One in five people who take nirmatrelvir/ritonavir (Paxlovid) get COVID-19 again after the drug clears them of it, according to a new study.
Paxlovid cuts COVID hospitalization, which may leave older adults weakened
By
Alicia Lasek
Dec 02, 2022
The CDC reports that COVID patients treated with the antiviral Paxlovid have a 51% lower risk of hospitalization, while another study has tied acute-care stays to muscle loss and long COVID.
LTC vaccinators opt to briefly halt J&J shots while awaiting FDA guidance
By
Alicia Lasek
Apr 14, 2021
Long-term care pharmacies and clinicians have temporarily paused their use of Johnson & Johnson’s COVID vaccine following recommendations from health officials. Guidance is needed quickly in order to...